Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

LB Pharmaceuticals announced promising Phase II results for LB-102 in schizophrenia, demonstrating symptom improvement.

Explore the molecular changes in Rett syndrome. Find out how this breakthrough could lead to more effective treatments.

Explore the collaboration between UVA Center for Diabetes Technology and Tandem Diabetes Care to transform insulin delivery ...

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

A study by Mount Sinai and Memorial Sloan Kettering researchers uncovers how neurotransmitters regulate brain gene expression ...

Macrocycles outperform traditional therapeutics on several fronts, yet they account for just four percent of FDA-approved drugs. Colleagues Ann E Cleves and Ajay N Jain from Optibrium Ltd explain why ...

Researchers at the Medical University of South Carolina have discovered a key genetic mechanism that could lead to RNA-based therapies for psychiatric disorders triggered by emotional experiences.